The Phase Ib trial is set to test a gene therapy designed to target a rare disorder that causes muscle and respiratory failure.

Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome ...

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed potential in protecting the brain in studies.

Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases: Hamburg, Germany Thursday, January 23, 2025, 10:00 Hrs [IST] Evotec SE, ...

Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent and tissue-targeted medicines, today announced the dosing of the first patient in its clinical trial of ABX1100, a ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

The Covid-19 outbreak in 2020 was on a scale not seen since the Spanish flu pandemic in 1918 and laid bare our lack of ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration ...

FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing ...

GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 23, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company dis ...

The SNU BioTalk 2025 an International Conference, themed "Symphony of Cellular Signals in Metabolism and Immune Response," ...

PRESIDENT Ferdinand R. Marcos Jr. is eyeing more engagements with the Asian Development Bank (ADB) in the coming years as the multilateral lender remains one of the country’s “constructive” partners ...